Omeprazole, a first-generation Proton Pump Inhibitor (PPI), has fundamentally transformed the clinical management of acid-related gastrointestinal disorders since its inception. As a selective and irreversible inhibitor of the H+/K+ ATPase enzyme system, Omeprazole Capsules IP 20mg serve as the gold standard for treating Gastric Ulcers, Duodenal Ulcers, and Gastroesophageal Reflux Disease (GERD). The "IP" (Indian Pharmacopoeia) designation signifies a rigorous adherence to specific purity, dissolution, and stability standards that are increasingly recognized by global procurement agencies for their balance of efficacy and cost-efficiency.
In the current pharmaceutical landscape, the demand for high-quality Omeprazole is no longer just about the molecule itself, but about the delivery technology. Delayed-release enteric-coated granules within the capsule ensure that the active pharmaceutical ingredient (API) bypasses the acidic environment of the stomach, reaching the small intestine for optimal absorption. As a premier supplier, Jiangxi Serum Pharma Industries Co., Ltd. leverages nearly a decade of expertise to bridge the gap between advanced manufacturing and global accessibility.
Established
Global Clients
Strategic Partners
Annual Revenue
The pharmaceutical manufacturing sector in China has undergone a paradigm shift. Moving beyond "Mass Production," the industry has embraced Industry 4.0 principles, integrating Artificial Intelligence (AI), the Internet of Things (IoT), and big data analytics into the production of Omeprazole Capsules.
Automated granulation and encapsulation systems ensure zero-defect production, maintaining consistent 20mg dosage accuracy across billions of units.
Real-time monitoring of environmental parameters (humidity/temperature) during the enteric coating process ensures maximum shelf-life stability.
End-to-end traceability from API sourcing to final dispatch, providing international buyers with complete batch documentation and compliance reports.
Serum Pharma continuously monitors the development of cutting-edge markets. Currently, we have already cooperated with our partners on the customization of Pre-Mix, Co-Crystallization, and Bio-Fermentation products and services. Our pharmaceutical products consist of biological products, vaccines, western medicines, raw materials, intermediates, and medical consumables, all with high quality and affordable prices.
Optimized formulations for rapid secondary manufacturing.
Enhancing API stability and bioavailability through molecular engineering.
Sustainable production methods for nutritional and pharmaceutical ingredients.
The global demand for Omeprazole Capsules IP 20mg is projected to grow at a CAGR of 4.5% over the next five years. This surge is driven by several key factors:
For B2B buyers—ranging from hospital chains in Southeast Asia to Ministry of Health distributors in Africa—the focus has shifted from "lowest price" to "highest reliability." Jiangxi Serum Pharma meets this need by providing high-efficacy Western medicines coupled with the logistical efficiency of a China-based hub.
Our nutritional ingredients cover several categories such as plant extracts, plant oils & proteins, probiotics, and other specialties. We are committed to exploring more health ingredients to support people’s health, deriving from nature to maintain body health and balance with purity.
A1: "IP" stands for Indian Pharmacopoeia. It dictates the specific analytical methods, purity standards, and dissolution profiles required. 20mg is the standard therapeutic dose for most acid-reflux conditions, providing an optimal balance between efficacy and safety.
A2: We use advanced moisture-barrier blister packaging (Alu-Alu or PVC/PVDC) and specialized enteric coating that withstands higher humidity levels, ensuring the product remains potent throughout its shelf life in diverse global regions.
A3: Yes, we provide comprehensive documentation including COA (Certificate of Analysis), GMP certifications, and stability data to support our clients' registration processes in their local markets.
A4: Depending on the volume and customization (e.g., private labeling), our lead time typically ranges from 15 to 30 days, supported by our robust supply chain network in China.
Analysis of the shifting trends towards sustainable sourcing in the pharmaceutical and cosmetic industries.
Apr 24, 2026Why this API remains a critical molecule in modern medicine and emergency care protocols.
Apr 17, 2026Insights into the FDA approval of Lilly's oral GLP1 and its impact on the weight-loss drug market.
Apr 08, 2026
